- call +1-201-465-4211
- email sales@mrinsights.biz
Celiac disease is a genetic, auto-immune disorder that affects the small intestine upon consumption of gluten. Celiac diseases may contribute to various diseases and disorders such as low bone density, neurological disorders, infertility, and certain cancers.
Scope of the Report:
This report studies the Celiac Disease Drugs market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Celiac Disease Drugs market by product type and applications/end industries.
The global Celiac Disease Drugs market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Celiac Disease Drugs.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Roche
Merck
Johnson & Johnson
BiolineRx
Pfizer
Innovate Biopharmaceuticals
ImmusanT
Novartis
Immunomedics
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
First Line of Treatment
Second Line of Treatment
Market Segment by Applications, can be divided into
Hospital
Research
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Celiac Disease Drugs Market Overview
1.1 Product Overview and Scope of Celiac Disease Drugs
1.2 Classification of Celiac Disease Drugs by Types
1.2.1 Global Celiac Disease Drugs Revenue Comparison by Types (2017-2023)
1.2.2 Global Celiac Disease Drugs Revenue Market Share by Types in 2017
1.2.3 First Line of Treatment
1.2.4 Second Line of Treatment
1.3 Global Celiac Disease Drugs Market by Application
1.3.1 Global Celiac Disease Drugs Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospital
1.3.3 Research
1.4 Global Celiac Disease Drugs Market by Regions
1.4.1 Global Celiac Disease Drugs Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Celiac Disease Drugs Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Celiac Disease Drugs Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Celiac Disease Drugs Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Celiac Disease Drugs Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Celiac Disease Drugs Status and Prospect (2013-2023)
1.5 Global Market Size of Celiac Disease Drugs (2013-2023)
2 Manufacturers Profiles
2.1 Roche
2.1.1 Business Overview
2.1.2 Celiac Disease Drugs Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Roche Celiac Disease Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.2 Merck
2.2.1 Business Overview
2.2.2 Celiac Disease Drugs Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Merck Celiac Disease Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.3 Johnson & Johnson
2.3.1 Business Overview
2.3.2 Celiac Disease Drugs Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Johnson & Johnson Celiac Disease Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.4 BiolineRx
2.4.1 Business Overview
2.4.2 Celiac Disease Drugs Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 BiolineRx Celiac Disease Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.5 Pfizer
2.5.1 Business Overview
2.5.2 Celiac Disease Drugs Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Pfizer Celiac Disease Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.6 Innovate Biopharmaceuticals
2.6.1 Business Overview
2.6.2 Celiac Disease Drugs Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Innovate Biopharmaceuticals Celiac Disease Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.7 ImmusanT
2.7.1 Business Overview
2.7.2 Celiac Disease Drugs Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 ImmusanT Celiac Disease Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.8 Novartis
2.8.1 Business Overview
2.8.2 Celiac Disease Drugs Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Novartis Celiac Disease Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.9 Bristol-Myers Squibb Company
2.9.1 Business Overview
2.9.2 Celiac Disease Drugs Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Bristol-Myers Squibb Company Celiac Disease Drugs Revenue, Gross Margin and Market Share (2016-2017)
2.10 Immunomedics
2.10.1 Business Overview
2.10.2 Celiac Disease Drugs Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Immunomedics Celiac Disease Drugs Revenue, Gross Margin and Market Share (2016-2017)
3 Global Celiac Disease Drugs Market Competition, by Players
3.1 Global Celiac Disease Drugs Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Celiac Disease Drugs Players Market Share
3.2.2 Top 10 Celiac Disease Drugs Players Market Share
3.3 Market Competition Trend
4 Global Celiac Disease Drugs Market Size by Regions
4.1 Global Celiac Disease Drugs Revenue and Market Share by Regions
4.2 North America Celiac Disease Drugs Revenue and Growth Rate (2013-2018)
4.3 Europe Celiac Disease Drugs Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Celiac Disease Drugs Revenue and Growth Rate (2013-2018)
4.5 South America Celiac Disease Drugs Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Celiac Disease Drugs Revenue and Growth Rate (2013-2018)
5 North America Celiac Disease Drugs Revenue by Countries
5.1 North America Celiac Disease Drugs Revenue by Countries (2013-2018)
5.2 USA Celiac Disease Drugs Revenue and Growth Rate (2013-2018)
5.3 Canada Celiac Disease Drugs Revenue and Growth Rate (2013-2018)
5.4 Mexico Celiac Disease Drugs Revenue and Growth Rate (2013-2018)
6 Europe Celiac Disease Drugs Revenue by Countries
6.1 Europe Celiac Disease Drugs Revenue by Countries (2013-2018)
6.2 Germany Celiac Disease Drugs Revenue and Growth Rate (2013-2018)
6.3 UK Celiac Disease Drugs Revenue and Growth Rate (2013-2018)
6.4 France Celiac Disease Drugs Revenue and Growth Rate (2013-2018)
6.5 Russia Celiac Disease Drugs Revenue and Growth Rate (2013-2018)
6.6 Italy Celiac Disease Drugs Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Celiac Disease Drugs Revenue by Countries
7.1 Asia-Pacific Celiac Disease Drugs Revenue by Countries (2013-2018)
7.2 China Celiac Disease Drugs Revenue and Growth Rate (2013-2018)
7.3 Japan Celiac Disease Drugs Revenue and Growth Rate (2013-2018)
7.4 Korea Celiac Disease Drugs Revenue and Growth Rate (2013-2018)
7.5 India Celiac Disease Drugs Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Celiac Disease Drugs Revenue and Growth Rate (2013-2018)
8 South America Celiac Disease Drugs Revenue by Countries
8.1 South America Celiac Disease Drugs Revenue by Countries (2013-2018)
8.2 Brazil Celiac Disease Drugs Revenue and Growth Rate (2013-2018)
8.3 Argentina Celiac Disease Drugs Revenue and Growth Rate (2013-2018)
8.4 Colombia Celiac Disease Drugs Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Celiac Disease Drugs by Countries
9.1 Middle East and Africa Celiac Disease Drugs Revenue by Countries (2013-2018)
9.2 Saudi Arabia Celiac Disease Drugs Revenue and Growth Rate (2013-2018)
9.3 UAE Celiac Disease Drugs Revenue and Growth Rate (2013-2018)
9.4 Egypt Celiac Disease Drugs Revenue and Growth Rate (2013-2018)
9.5 Nigeria Celiac Disease Drugs Revenue and Growth Rate (2013-2018)
9.6 South Africa Celiac Disease Drugs Revenue and Growth Rate (2013-2018)
10 Global Celiac Disease Drugs Market Segment by Type
10.1 Global Celiac Disease Drugs Revenue and Market Share by Type (2013-2018)
10.2 Global Celiac Disease Drugs Market Forecast by Type (2018-2023)
10.3 First Line of Treatment Revenue Growth Rate (2013-2023)
10.4 Second Line of Treatment Revenue Growth Rate (2013-2023)
11 Global Celiac Disease Drugs Market Segment by Application
11.1 Global Celiac Disease Drugs Revenue Market Share by Application (2013-2018)
11.2 Celiac Disease Drugs Market Forecast by Application (2018-2023)
11.3 Hospital Revenue Growth (2013-2018)
11.4 Research Revenue Growth (2013-2018)
12 Global Celiac Disease Drugs Market Size Forecast (2018-2023)
12.1 Global Celiac Disease Drugs Market Size Forecast (2018-2023)
12.2 Global Celiac Disease Drugs Market Forecast by Regions (2018-2023)
12.3 North America Celiac Disease Drugs Revenue Market Forecast (2018-2023)
12.4 Europe Celiac Disease Drugs Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Celiac Disease Drugs Revenue Market Forecast (2018-2023)
12.6 South America Celiac Disease Drugs Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Celiac Disease Drugs Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Celiac Disease Drugs Picture
Table Product Specifications of Celiac Disease Drugs
Table Global Celiac Disease Drugs and Revenue (Million USD) Market Split by Product
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
